))
Neuroscience research summaries as delivered by chatty podcasters from Google Notebook LM
…
continue reading
1
The Parkinson’s Research Podcast: New Discoveries in Neuroscience
The Michael J. Fox Foundation for Parkinson’s Research
In this podcast, The Michael J. Fox Foundation for Parkinson’s Research brings you right to the cutting edge of neuroscience to discuss the latest discoveries in the field of neuroscience, with a focus on Parkinson’s disease (PD). We are working at the forefront of PD research to accelerate scientific breakthroughs by providing funding opportunities, tools and resources to develop new treatments, find cures and improve quality of life for people living with Parkinson’s disease. If you’re a s ...
…
continue reading
In this short episode, host Dr. Marie McNeely shares updates about the podcast and provides listeners with more information on how they can stay connected with MJFF for future podcast episodes as The Parkinson’s Research Podcast merges with The Michael J. Fox Foundation Parkinson’s Podcast. Visit https://www.michaeljfox.org/podcasts for more great …
…
continue reading
1
30: The Role of Diet and Nutrition in Parkinson’s Disease and Brain Health with Puja Agarwal
42:25
It is widely known that a healthy diet can provide essential nutrients and lead to a multitude of benefits, but growing evidence has highlighted important links between diet, nutrition, and brain health, particularly related to neurodegenerative disease. In this episode, Dr. Puja Agarwal discusses her research investigating the role that diet and n…
…
continue reading
1
29: Developing a Novel App to Improve Speech Intelligibility in Parkinson's Disease with Gemma Moya-Galé
43:47
Parkinson's disease significantly impacts various aspects of communication, and this can make it challenging for people with the disease to communicate effectively, be understood by others, and engage in social situations. Dr. Gemma Moya-Galé joins this episode to talk about her work on voice and communication in people with Parkinson’s disease. In…
…
continue reading
1
28: Increasing Diversity in Research and Addressing Brain Health Inequities with Monica Rivera-Mindt
44:05
Certain populations are disproportionately affected by neurological diseases, including Parkinson's and other neurodegenerative diseases. A lot of work remains to be done to improve brain health outcomes and promote healthy brain aging across the lifespan, particularly for minoritized, underrepresented populations. Including participants from diver…
…
continue reading
1
27: The Development and Application of the Alpha-Synuclein Seed Amplification Assay with Claudio Soto
37:27
Alpha-synuclein plays a key role in the pathophysiology of Parkinson's disease, and researchers have been investigating this protein as a therapeutic target and also as a potential biomarker for the disease. The alpha-synuclein seed amplification assay, developed by Dr. Claudio Soto and colleagues, leverages the self-replicating nature of the misfo…
…
continue reading
This study looked at whether eating meat is linked to dementia in older adults. The researchers used information from a large group of people in the UK Biobank and found that eating processed meat was associated with an increased risk of developing all-cause dementia and Alzheimer's disease. However, eating unprocessed red meat was associated with …
…
continue reading
My favorite floss: https://cocofloss.com/ (not an affiliate link, just a fan) Summary:Hepatitis C and herpes simplex virus 2 infections make you more likely to develop dementia. Many people have been infected with these viruses, making them important risk factors for dementia.Having many infections over your lifetime plus gum disease with certain b…
…
continue reading
Original study: https://www.nejm.org/doi/full/10.1056/NEJMoa1215740 This study looked at a large group of people, some with diabetes and some without, to see if there was a link between their blood sugar levels and their risk of developing dementia. They found that people with higher blood sugar levels, even those without diabetes, were more likely…
…
continue reading
This scoping review, titled "Diet and Anxiety: A Scoping Review," summarizes the current scientific literature on the relationship between diet and anxiety. It analyzes numerous studies, both human and animal, to assess how various dietary factors, such as the intake of specific nutrients, dietary patterns, and the gut microbiome, impact anxiety sy…
…
continue reading
Research report: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(21)00275-2/fulltext Research summarized by Google's Notebook LM You can find me at https://instagram.com/theinevitabledanielleDi Danielle Vincent
…
continue reading
Research is here: https://pmc.ncbi.nlm.nih.gov/articles/PMC1448497/ This is an AI-generated podcast that summarizes research studies about neuroscience. It is generated with Google LM. You can find me at //instagram.com/theinevitabledanielleDi Danielle Vincent
…
continue reading
Here's the research: https://link.springer.com/article/10.1007/s11187-018-0061-1 This is an AI-generated podcast that summarizes research studies about neuroscience. It is generated with Google LM. You can find me at //instagram.com/theinevitabledanielleDi Danielle Vincent
…
continue reading
Here's the research: https://pubmed.ncbi.nlm.nih.gov/39199177/ This is an AI-generated podcast that summarizes research studies about neuroscience. It is generated with Google LM. You can find me at https://instagram.com/theinevitabledanielleDi Danielle Vincent
…
continue reading
1
26: An Inside Look at the Edmond J. Safra Fellowship in Movement Disorders with Marcelo Merello and Sergio Castillo-Torres
57:54
To help meet the growing global need for more movement disorders specialists, The Michael J. Fox Foundation created the Edmond J. Safra Fellowship in Movement Disorders in collaboration with longtime partner the Edmond J. Safra Foundation. This program supports the training of movement disorders specialists who will provide expert care and drive ad…
…
continue reading
Information from the NIH as presented by Google's Notebook LM find the original article here: https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-happens-brain-alzheimers-disease You can find me at https://instagram.com/theinevitabledanielleDi Danielle Vincent & Google Notebook LM
…
continue reading
A recap of the most recent study from The Lancet Commission on dementia prevention research: https://www.thelancet.com/commissions/dementia-prevention-intervention-care?dgcid=tlcom_infographic_demetia-risks-24_lancet This podcast was made with Notebook LM You can find me at https://instagram.com/theinevitabledanielle…
…
continue reading
Stem cell models derived from patients with Parkinson’s disease are valuable tools that are helping researchers around the world to better understand the underlying causes of neurodegeneration and to develop biomarkers and new therapies. To maximize the potential impacts of these tools, it is critical that they are developed and shared according to…
…
continue reading
1
24: Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen
35:48
New qualitative and quantitative tools are being developed to measure and track changes in proteins relevant for neurodegenerative disease, and these tools have the potential to accelerate drug discovery and clinical trials. In this episode, Dr. Judith Steen discusses her work creating novel qualitative and quantitative tools and workflows at the i…
…
continue reading
1
23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler
45:52
Substantial research has focused on identifying biomarkers for the diagnosis of Parkinson's disease (PD) as well as monitoring progression of the disease. In developing these biomarkers, it is critical for scientists to consider how the biomarkers will ultimately be used in the clinic and in clinical trials research. In this interview, Dr. Charles …
…
continue reading
1
22: Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl
41:20
Sleep disturbances, such as insomnia, sleep fragmentation, excessive daytime sleepiness, and REM sleep behavior disorder are common in people with Parkinson's disease (PD). Poor sleep quality can also impact other domains of function, including motor function. Prior research has shown that a type of photoreceptor cell in the retina, called melanops…
…
continue reading
1
21: The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue
31:54
Though existing evidence supports that dysfunction in the clearing of cellular debris plays an important role in the development of Parkinson's disease, many unanswered questions remain regarding the mechanisms of the autophagy-lysosomal pathway involved in this process. In particular, research in the field has been limited by a lack of reliable, q…
…
continue reading
1
20: Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor
47:28
Evidence supports that dysfunction in the homeostasis of iron and other elements likely contributes to the pathophysiological mechanisms of Parkinson's disease, but we have yet to develop suitable elemental biomarkers for use in diagnosing and monitoring the progression of Parkinson's disease. Dr. Paul Lingor discusses his work in this area to iden…
…
continue reading
1
19: Current and Emerging Imaging Biomarkers for Diagnosis and Prognosis of PD and Atypical Parkinsonism with Antonio Strafella
37:29
Identifying reliable biomarkers for the diagnosis and prognosis of Parkinson's disease and atypical parkinsonism would have substantial impacts on clinical trials and clinical practice. A particularly active area of research is the development of novel molecular imaging biomarkers that can be used in combination with common neuroimaging approaches.…
…
continue reading
1
18: Examining Links Between Environmental Exposure, Poor Olfaction, and Parkinson's Disease with Honglei Chen
46:47
Prior studies have established links between poor olfaction and Parkinson's disease, and impaired sense of smell is a common prodromal symptom of Parkinson's disease. The causes and mechanisms of prodromal neurodegeneration are actively being researched. However, environmental exposure to pesticides or other chemicals may trigger or modify the cour…
…
continue reading
1
17: Developing Interventions to Improve Gait and Increase Physical Activity in Parkinson’s Disease with Gammon Earhart
42:37
Gait impairments such as slow speed, small steps, and high variability from step to step are common in people with Parkinson's disease, and these changes begin to occur early in the course of disease. Freezing of gait may develop later for some individuals, and it has been linked to falls and other adverse outcomes. When the quality of walking decl…
…
continue reading
1
16: Studying Basal Ganglia Circuits and Developing Deep Brain Stimulation Protocols for Longer-Lasting Effects with Aryn Gittis
44:21
Improving our understanding of the complex neural circuits involved in normal function of the basal ganglia and other parts of the brain impacted by Parkinson's disease is critical for developing more targeted and more effective treatment approaches. In this episode, Dr. Aryn Gittis discusses her research examining how the activity of specific basa…
…
continue reading
1
15: Innovative Fellowship Program is Training Tomorrow's Parkinson's Leaders with Rachel Dolhun
40:10
Demand for movement disorder specialists continues to grow, but not enough neurologists are receiving focused training in Parkinson’s and related conditions in order to meet the current and projected needs in the U.S. and around the world. In collaboration with longtime partner the Edmond J. Safra Foundation, The Michael J. Fox Foundation created t…
…
continue reading
1
14: Evidence Linking Parkinson's Disease Risk and Environmental Exposure to Trichloroethylene (TCE) with Sam Goldman
39:22
Trichloroethylene (TCE) and related chemicals like perchloroethylene (PCE) have been used widely for a variety of commercial purposes over the past century, and these chemicals are prevalent in the air, water, and soil. Over the past several decades, mounting evidence has been published linking exposure to TCE/PCE with adverse health effects, inclu…
…
continue reading
For over a century, different surgical interventions have been explored to address symptoms of Parkinson's disease, and researchers are continuing to innovate and improve surgical treatments today. With new technology and an ever-expanding understanding of the function of the nervous system and the pathophysiology of Parkinson's disease, neurosurgi…
…
continue reading
1
12: Accelerating Discovery by Developing and Distributing Research Tools with Nicole Polinski
33:42
The Michael J. Fox Foundation for Parkinson's Research established its Research Tools Program to address gaps in the field and common challenges surrounding the development of reagents and models that slowed the initial stages of promising research projects. In collaboration with many partners and stakeholders, the Research Tools Program helps ensu…
…
continue reading
1
11: The Importance of Sex and Gender Factors in Neurodegenerative Disease Research and Care with Antonella Santuccione Chadha
46:33
Increasing evidence supports the presence of sex and gender differences in neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease. There is a critical need to more closely examine sex and gender differences in all stages of research, therapeutic development, and clinical treatment to enable better outcomes through preci…
…
continue reading
1
10: Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris
43:54
Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies are often initially diagnosed as Parkinson's disease. Incorrect, incomplete, or delayed diagnoses are barriers to beginning the most appropriate treatment early in the disease c…
…
continue reading
1
9: Examining the Proposed Biological Definition of Neuronal Alpha-Synuclein Disease and Staging System with Lana Chahine
38:04
For many years, Parkinson's disease and dementia with Lewy bodies have been defined using clinical features. With recent advances in biomarkers, particularly the alpha-synuclein seed amplification assay that allows us to detect misfolded and aggregated alpha-synuclein in cerebrospinal fluid, it is now possible to identify the presence of pathologic…
…
continue reading
1
8: Managing Risk for Drug Discovery and Development in Parkinson's Disease with Kalpana Merchant
1:07:19
1:07:19
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:07:19
There is a pressing need to develop safe and effective disease-modifying and symptomatic treatments for Parkinson's disease. Through improvements in our understanding of the pathophysiology of the disease, as well as genetic risk factors, new potential treatment targets have emerged. However, bringing a promising new compound from the lab through a…
…
continue reading
1
7: Using Neuroimaging and Biomarkers to Improve Neurodegenerative Disease Diagnosis and Assessment with John Seibyl
52:41
In neurodegenerative conditions such as Parkinson's disease (PD), patients often do not receive a diagnosis until the hallmark motor symptoms begin to manifest. This can be a decade or more after substantial changes start occurring in the brain. A major goal of the PD research field has been to develop methods for earlier detection and intervention…
…
continue reading
A substantial portion of people with Parkinson's disease (PD) have a family history of the disease, and new findings continue to improve our understanding of relevant genetic variants. These discoveries are key for clarifying the mechanisms that lead to Parkinson's disease as well as the development of new therapies. The Global Parkinson's Genetics…
…
continue reading
1
5: The Role of Inflammation and Immune Responses in Neurodegeneration with Malú Gámez Tansey
51:37
A growing body of evidence is expanding our understanding of the links between inflammation, our immune responses, brain health, and neurodegeneration. In particular, several genes associated with Parkinson's (including LRRK2) are known to be involved in inflammation, and peripheral inflammation has been shown to influence brain function and contri…
…
continue reading
Mutations in the LRRK2 gene were first linked to Parkinson's disease (PD) risk in 2004. Since then, researchers from around the world have advanced our understanding of the mechanisms through which LRRK2 may contribute to PD, leading to the development of three potential LRRK2-targeted therapies that are now being evaluated in clinical trials. Alon…
…
continue reading
1
3: New Frontiers in Deep Brain Stimulation Research for Parkinson’s disease with Michael Okun
54:01
For decades, researchers, clinicians, and industry professionals have continued to study and optimize deep brain stimulation (DBS) with the goal of providing the best possible personalized treatment for Parkinson’s disease (PD) and other neurological conditions. In this episode, Dr. Michael Okun joins us to discuss his research and some of the rece…
…
continue reading
Sleep impacts our lives in many different ways, and Dr. Amy Amara joins us in this episode to discuss her career and findings from her research on sleep in Parkinson’s disease (PD). She shares her insights on the characteristics of sleep in people with Parkinson’s disease, how sleep can be impacted by exercise, medications, and deep brain stimulati…
…
continue reading
In this episode, serial entrepreneur Dr. Karoly Nikolich shares his perspectives on the industry side of the state of neuroscience, as well as areas of opportunity and the role of industry in advancing the field. He also discusses recent major breakthroughs, the importance of industry partnerships, including collaborations with The Michael J. Fox F…
…
continue reading
1
0: The Parkinson's Research Landscape and the Role of MJFF with Brian Fiske and Mark Frasier
36:56
New research advances are expanding our knowledge of Parkinson's disease and bringing us closer to the ultimate goals of new treatments, effective cures, and disease prevention. In this introductory episode, you'll hear from Dr. Brian Fiske and Dr. Mark Frasier, Co-Chief Scientific Officers at The Michael J. Fox Foundation for Parkinson's Research …
…
continue reading
